Explorer les evidences

1 800 000 personsIn 2018, an estimated 1.8 million persons living in Nigeria had HIV infection, representing 1.3% of the total population.

NigeriaVIH/sidaobservé 2018publié 2021MMWR. Morbidity and mortality weekly reportPubMeddocument de 6 observations

Next Generation Sequencing on 1st of October revealed one full and two partial RHDV2 genomes on both farms in Ibadan, Nigeria.

NigeriaRHDV2observé 2020-10-01publié 2020Microbial Metagenomic Approach Uncovers the First Rabbit Haemorrhagic Disease Virus genomeeurope_pmcdocument de 5 observationsDOI 10.1101/2020.11.19.390559

0,403 correlation_coefficientThere was a significant positive correlation between awareness of low malaria transmission and malaria diagnosis (r = 0.403, P < 0.001).

Nigeriapaludismepublié 2025Scientific reportsPubMeddocument de 14 observations

44,2 %Among 240 booked pregnant women in Oyo state, 44.2% of HIV-negative respondents reported being abused in the index pregnancy.

NigeriaVIH/sidaobservé 2019publié 2023Journal of the International Association of Providers of AIDS CarePubMeddocument de 6 observations

95 %Greater than 95% of pre-treatment parasitaemia was cleared by 24 hours after commencement of treatment in all groups.

Nigeriapaludismepublié 1996Acta tropicaeurope_pmcdocument de 8 observations

10 015 participantsA total of 10015 participants representing 14.4% of ART clients in 50 hospitals opted for the community pharmacy ART refill model.

NigeriaVIH/sidaobservé October 2016 to February 2018publié 2021Research in social & administrative pharmacy : RSAPPubMeddocument de 6 observations

11,8 %Among PLHIV aged 51–60 years, the prevalence of HBeAg was 11.8%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

11,1 %Cord blood malaria parasitaemia prevalence was 11.1%.

Nigeriapaludismepublié 2026Parasitology internationalPubMeddocument de 8 observations

2 500 NGNThe median maximum amount people living with HIV (PLHIV) on antiretroviral therapy (ART) were willing to pay for viral load testing services was NGN2,500 (USD $6.94), with an interquartile range of NGN1,000–NGN5,000.

NigeriaVIH/sidaobservé July and August 2019publié 2023PloS onePubMeddocument de 9 observations

18,2 %18.2% of the women cited not feeling susceptible to cervical cancer as a reason for not being screened.

Nigeriacancer du col de l'utéruspublié 2021The Pan African medical journalPubMeddocument de 8 observations

99,12 %Viral suppression was 99.12%.

NigeriaVIH/sidaobservé October 2016 to February 2018publié 2021Research in social & administrative pharmacy : RSAPPubMeddocument de 6 observations

13,9 %Among male PLHIV participants, the prevalence of HBsAg was 13.9%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

55,09 %Diabetic foot ulcers predominantly affected the left foot in 55.09% of cases in Nigeria.

Nigeriapied diabétiquepublié 2026Journal of epidemiology and global healthPubMeddocument de 12 observations

55,4 %The prevalence of elevated total cholesterol among respondents was 55.4%.

Nigeriaelevated total cholesterolpublié 2020BMC cardiovascular disordersPubMeddocument de 11 observations

20,38 %The prevalence of diabetic foot ulcers was highest in the Southwest region of Nigeria at 20.38%.

Nigeriapied diabétiquepublié 2026Journal of epidemiology and global healthPubMeddocument de 12 observations

Patients without periprosthetic joint infection recorded statistically significant improvement in Visual Analogue Scale score (p = 0.000) at three months.

Nigeriaperiprosthetic joint infectionobservé three monthspublié 2026Journal of ISAKOS : joint disorders & orthopaedic sports medicinePubMeddocument de 3 observations

63,3 %Mefloquine produced a parasite reduction of 63.3% at 24 hours.

Nigeriapaludismepublié 1996Annals of tropical paediatricseurope_pmcdocument de 6 observations

17 deathsSeventeen (1.4%) patients with sickle cell disease and respiratory morbidities died.

Nigeriadrépanocytose · respiratory morbiditiesobservé 2012 to 2021publié 2024PloS onePubMeddocument de 12 observations

21 casesTwenty-one (95.5%) high risk infants had their first PCR screening between 3 and 14 months.

NigeriaVIH/sidapublié 2025West African journal of medicinePubMeddocument de 8 observations

35,4 scoreThe post-intervention overall symptom domain score was 35.4 ± 12.4 for the control group.

Nigeriacancer du seinpublié 2021Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 8 observations

1,57 adjusted_odds_ratioDuration of illness >3 days was an independent risk factor for the presence of gametocytaemia at enrolment with adjusted odds ratio = 1.57.

Nigeriapaludismepublié 2004Parasitologyeurope_pmcdocument de 10 observations

24,3 %Rifampicin resistance was observed in 9 out of 37 (24.3%) HIV-positive tuberculosis patients in the North Central zone of Nigeria.

Nigeriatuberculose · VIH/sidapublié 2019Journal of epidemiology and global healthPubMeddocument de 7 observations

37 %The pooled prevalence of cervical papillomavirus infection was 37% among women living with HIV/AIDS in Nigeria.

Nigeriainfection à HPVpublié 2020Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 2 observations

33,4 %The overall prevalence of hypertension was 33.4% among the 1460 participants from four communities situated at varying distances from the refinery.

Nigeriahypertension artériellepublié 2025Nigerian journal of clinical practicePubMeddocument de 6 observations

2 124 casesIn Nigeria, there were 2,124 cholera cases and 68 deaths from January 2025 to July 2025.

Nigeriacholéraobservé Jan 2025 – 31 July 2025Africa CDCdocument de 176 observations